DESIGN AND DEVELOPMENT OFA 68GA/177LU-LABELED UNIVERSAL BOMBESIN PEPTIDE LIGAND FOR IMAGING AND THERAPY OF BOMBESIN RECEPTOR-EXPRESSING TUMORS

被引:0
|
作者
Okarvi, S. M. [1 ]
AlJammaz, I. [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Cyclotron & Radiopharmaceut Dept, Riyadh 11211, Saudi Arabia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S146 / S146
页数:1
相关论文
共 45 条
  • [1] Development of a 68Ga/177Lu-labeled universal bombesin peptide ligand for the diagnosis and targeted therapy of bombesin receptor-expressing tumors.
    Okarvi, S.
    AlJammaz, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S274 - S275
  • [2] Synthesis and Evaluation of 68Ga- and 177Lu-Labeled [Pro14]bombesin(8-14) Derivatives for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
    Wang, Lei
    Kuo, Hsiou-Ting
    Chapple, Devon E.
    Chen, Chao-Cheng
    Kurkowska, Sara
    Colpo, Nadine
    Uribe, Carlos
    Benard, Francois
    Lin, Kuo-Shyan
    MOLECULAR PHARMACEUTICS, 2024, 21 (12) : 6385 - 6397
  • [3] Synthesis and Evaluation of 68Ga- and 177Lu-Labeled [diF-Pro14]Bombesin(6-14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
    Wang, Lei
    Chen, Chao-Cheng
    Chapple, Devon
    Wong, Antonio A. W. L.
    Kurkowska, Sara
    Lau, Wing Sum
    Uribe, Carlos F.
    Benard, Francois
    Lin, Kuo-Shyan
    PHARMACEUTICALS, 2025, 18 (02)
  • [4] Preparation and evaluation of a Tc-99m-labeled bombesin peptide derived from the universal sequence for targeting bombesin receptor-expressing tumors
    Okarvi, S. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S221 - S221
  • [5] Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors
    Okarvi, Subhani M.
    Al Jammaz, Ibrahim
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (03) : 277 - 288
  • [6] Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
    Oscar Ardenfors
    Joachim N. Nilsson
    Daniel Thor
    Cecilia Hindorf
    EJNMMI Physics, 9
  • [7] Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
    Ardenfors, Oscar
    Nilsson, Joachim N.
    Thor, Daniel
    Hindorf, Cecilia
    EJNMMI PHYSICS, 2022, 9 (01)
  • [8] Development and Evaluation of Novel 68Ga/177Lu-Labeled PSMA Inhibitors with Enhanced Pharmacokinetics and Tumor Imaging for Prostate Cancer
    Li, Haiyang
    Liu, Yang
    Yuan, Hongmei
    Cai, Ping
    Wu, Tongtong
    Yang, Zhicong
    Nie, Jiaqi
    Zhang, Wei
    Huang, Zhanwen
    Liu, Nan
    Chen, Yue
    Zhou, Zhijun
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1584 - 1597
  • [9] Targeting gastrin-releasing peptide receptor-expressing tumors with 18F-labeled bombesin analog
    Dijkgraaf, I.
    Franssen, G. M.
    McBride, W. J.
    D'Souza, C.
    Smith, C. J.
    Goldenberg, D. M.
    Oyen, W. J. G.
    Boerman, O. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S229 - S229
  • [10] Synthesis, Radiolabeling, and Preclinical Evaluation of 68Ga/177Lu-Labeled Leuprolide Peptide Analog for the Detection of Breast Cancer
    Okarvi, Subhani M.
    Al-Jammaz, Ibrahim
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (05) : 372 - 383